CCM
Compton Capital Management Portfolio holdings
AUM
$4.32M
Turnover
83.33%
1-Year Est. Return
27.38%
This Fund
S&P 500
This Quarter
Est. Return
-9.03%
1 Year Est. Return
+27.38%
3 Year Est. Return
+75.57%
5 Year Est. Return
+123.58%
10 Year Est. Return
+303.58%
AUM
$278M
AUM Growth
+$95.8M
(+53%)
Cap. Flow
-$2.91M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
61.72%
Holding
141
New
1
Increased
29
Reduced
66
Closed
9
Avg Time Held
2
years
Top 10 Avg Time Held
2
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$511K |
| 2 |
Invesco Preferred ETF
PGX
|
+$423K |
| 3 |
Viatris
VTRS
|
+$349K |
| 4 |
Microsoft
MSFT
|
+$320K |
| 5 |
Johnson & Johnson
JNJ
|
+$175K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$288K |
| 2 |
APA Corp
APA
|
+$281K |
| 3 |
Gilead Sciences
GILD
|
+$264K |
| 4 |
Fluor
FLR
|
+$252K |
| 5 |
TWX
Time Warner Inc
TWX
|
+$237K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 51.09% |
| 2 | Healthcare | 11.8% |
| 3 | Financials | 8.47% |
| 4 | Industrials | 6.59% |
| 5 | Communication Services | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Air Products & Chemicals
APD
$65.1B
| $216K | 0.08% |
1,829
| – | – |
2014 Q1
6 quarters
|
|
127
DELISTED
Marathon Oil Corporation
MRO
| $215K | 0.08% |
13,955
-2,950
| -17% | -$56K |
2013 Q2
9 quarters
|
|
128
DuPont de Nemours
DD
$17.4B
| $210K | 0.08% |
1,960
| – | – |
2013 Q2
9 quarters
|
|
129
Agilent Technologies
A
$49.1B
| $204K | 0.07% |
5,931
-150
| -2% | -$5.67K |
2014 Q2
5 quarters
|
|
130
Freeport-McMoran
FCX
$100B
| $165K | 0.06% |
17,072
| – | – |
2013 Q2
9 quarters
|
|
|
RXII
131
DELISTED
GALENA BIOPHARMA INC COM
RXII
| $24K | 0.01% |
15,000
| – | – |
2014 Q2
5 quarters
|
|
132
Quantum Corp
QMCO
$940M
| $14K | 0.01% |
125
| – | – |
2013 Q2
9 quarters
|
|
|
133
APA Corp
APA
$16.6B
| – | – |
-4,875
| Closed | -$281K | – |
|
|
134
Fluor
FLR
$6.37B
| – | – |
-4,750
| Closed | -$252K | – |
|
135
GSK
GSK
$95.9B
| – | – |
-4,155
| Closed | -$216K | – |
|
136
Occidental Petroleum
OXY
$61.4B
| – | – |
-2,629
| Closed | -$204K | – |
|
137
Teva Pharmaceutical Industries Limited
TEVA
$47.5B
| – | – |
-3,765
| Closed | -$222K | – |
|
|
SCU
138
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| – | – |
-1,030
| Closed | -$126K | – |
|
|
TWX
139
DELISTED
Time Warner Inc
TWX
| – | – |
-2,707
| Closed | -$237K | – |
|
|
MON
140
DELISTED
Monsanto Co
MON
| – | – |
-1,950
| Closed | -$208K | – |
|
141
DELISTED
BARCLAYS BK PLC SPONSORED ADS SER 4 PREF SHS (UK)
BCS.PRC
| – | – |
-8,199
| Closed | -$212K | – |
|
Similar funds
GPCM
MAM
BGCI
CAM
EAM
SM
TPL
RC
Compton Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Compton Capital Management held 141 positions worth $278M, up 53% from $182M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Compton Capital Management's Q3 2015 filing shows 1 new, 29 increased, 66 reduced and 9 closed positions. Its largest new stake was Viatris: 6,255 shares worth $252K. The largest sale was AbbVie, an estimated $288K.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Compton Capital Management's largest Q3 2015 buy was Viatris: 6,255 shares worth $252K.
- Compton Capital Management added most to Walt Disney in Q3 2015, an estimated $511K increase.
- Compton Capital Management's biggest Q3 2015 reduction was AbbVie, cutting an estimated $288K.
- Compton Capital Management fully exited APA Corp in Q3 2015, selling an estimated $281K.
- Compton Capital Management's ten largest holdings make up 62% of its $278M portfolio in Q3 2015.
- Compton Capital Management opened 1 new position and closed 9 in Q3 2015.
- Compton Capital Management's portfolio value rose 53% quarter-over-quarter to $278M.
Based on Compton Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.